Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ATOVAQUONE, USP, with a corresponding US DMF Number 22121.
Remarkably, this DMF maintains an Active status since its submission on October 27, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 23, 2014, and payment made on May 16, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II